CHCWM – Cancer & Hematology Centers of West Michigan

KL264-01 (Klus)

A Phase I-II, First –in-Human Study of SKB264 in Patients with Locally Advanced Unresectable/Metastatic Solid Tumors who are refractory to Available Standard Therapies